P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS

• Erlie Jiang,
• Shulian Chen,
• Xiaoyu Zhang,
• Weihua Zhai,
• Ting Niu,
• Yajing Xu,
• Guangxun Gao,
• Shengjin Fan,
• Zeping Zhou,
• Fang Zhou,
• LI Liu,
• Wei Yang,
• Qifa Liu,
• XI Zhang,
• Hai Bai,
• Rui XI,
• Yi He,
• Sizhou Feng,
• Mingzhe Han

Affiliations

Erlie Jiang

1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin, China

Shulian Chen

1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin, China

Xiaoyu Zhang

1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin, China

Weihua Zhai

1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin, China

Ting Niu

2 West China Hospital, Sichuan University

Yajing Xu

3 Xiangya Hospital, Central South University

Guangxun Gao

4 Xijing Hospital, the Air Force Military Medical University

Shengjin Fan

5 The First Affiliated Hospital of Harbin Medical University

Zeping Zhou

6 The Second Affiliated Hospital of Kunming Medical University

Fang Zhou

7 The 960th Hospital of the Joint Logistics Support Force of Chinese People’s Liberation Army

LI Liu

8 The Second Affiliated Hospital of Air Force Military Medical University

Wei Yang

9 Shengjing Hospital of China Medical University

Qifa Liu

10 Nanfang Hospital, Southern Medical University

XI Zhang

11 The Second Affiliated Hospital, Army Medical University

Hai Bai

12 Shunde Hospital of Southern Medical University

Rui XI

13 The 940th Hospital of Joint Logistics Support Force of Chinese People’s Liberation Army

Yi He

1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin, China

Sizhou Feng

1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin, China

Mingzhe Han

1 Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Department of hematopoietic stem cell transplantation, Tianjin, China